Author:
Hale Geoff,Waldmann Herman
Reference58 articles.
1. von Behring, E. and Kitasato, S. (1890) Dtsch. Med.
Wochenshe. 16, 1113–1114.
2. Hericourt, J. and Richet, C. (1895) “Physologie
Pathologique”-de la serotherapie dans la traitement du cancer. Comptes
Rendus Hebd. Seanc. Acad. Sci.121, 567.
3. Currie, G. A. (1972) Eighty years of immunotherapy: a
review of immunological methods used for the treatment of human cancer.
Br. J. Cancer26, 141–153.
4. Prentice, H. G., Blacklock, H. A., Janossy, G.,
Bradstock, K. F., Skeggs, D., Goldstein, G., and Hoffbrand, A. V. (1982)
Use of anti-T cell monoclonal antibody OKT3 to prevent acute graft
versus host disease in allogeneic bone marrow transplantation for acute
leukemia. Lancet1, 700–703.
5. Filipovitch, A. H., Vallera, D. A., Youle, R. J.,
Haake, R., Blazar, B. R., Arthur, D., Neville, Ramsay, N. K., McGlave,
P., and Kersey, J. H. (1987) Graft-versus-host disease prevention in
allogeneic bone marrow transplantation from histo-compatible siblings. A
pilot study using immunotoxins for T cell depletion of donor bone
marrow. Transplantation44, 62–69.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献